Long-acting CAB+RPV is preferred by patients for ART due to reduced dosing frequency and stigma, with 89% switching after viral suppression. Studies like PILLAR and EBONI confirm the effectiveness and ...
Daily Maverick on MSN
The long shot: Building behavioural science into HIV prevention
Lenacapavir (LEN) has arrived in South Africa, and this injectable form of pre-exposure prophylaxis (PrEP) marks a major ...
The most useful thing about a new HIV-prevention guide may be a question it never asks: Why do you want to know about ...
A nurse at Tudor Sub-County Hospital in Mombasa administers Lenacapavir injection during the rollout of the vaccine on March 13, 2026. [Robert Menza, Standard] Mombasa County has officially rolled out ...
In a new brief report, researchers caution against repeating past mistakes in HIV prevention, as high drug prices and insurance coverage issues have slowed uptake of long-acting, bimonthly injectable ...
(RTTNews) - Gilead Sciences Inc. (GILD) announced that the U.S. Food and Drug Administration has approved Yeztugo (lenacapavir)-the company's injectable HIV-1 capsid inhibitor-as pre-exposure ...
ViiV's new awareness campaign educates consumers that there are different kinds of PrEP treatments, including long-lasting ...
The most useful thing about a new HIV prevention guide may be a question it never asks: Why do you want to know about pre-exposure prophylaxis, or PrEP? In a pilot study at three clinics, a two-page ...
The first ever injectable drug that can prevent HIV has been approved for use in England and Wales. The drug, cabotegravir, would benefit an estimated 1,000 people at risk of HIV in England and Wales.
Malawi breaking news publishing 24 hours a day news about Malawi, Malawi Business, Malawi Tourism, Malawi Politics, Malawi News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results